LGALS3 and hydrops fetalis: Galectin-3 has also been shown to be an independent predictor of mortality in patients with NYHA class III-IV HF and in the general population, with levels >25.9 ng/ml shown to be predictive of a rapid progression of HF [3, 6, 7].